Social distancing measures during the COVID-19 pandemic have profoundly impacted the way health care services are delivered. In order to reduce risk to both health care providers and to patients, as many services as possible...more
On Thursday, March 5, the Food and Drug Administration (FDA) submitted its long-awaited report on the agency’s activity related to regulation of cannabidiol (CBD) and CBD-containing products. The FDA was required to submit a...more
Developments are moving rapidly in Washington, D.C., as week-long negotiations on how the country should fund efforts to control coronavirus have reached a pivotal milestone. The negotiations began the final week of February...more
The Food and Drug Administration (FDA) released a final guidance on July 29, 2016, saying that it does not plan to require pre-market review for low-risk "general wellness products," such as wearable fitness monitors,...more